memantine has been researched along with fluoxetine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Frank, JG; Keller, A; Nuwayhid, SJ; Werling, LL | 1 |
| Dodman, N; Shuster, L; Wald, R | 1 |
| Delabar, JM | 1 |
| D'Amico, E; Leone, C; Patti, F | 1 |
| Jurica, J; Sabova, M; Sulcova, A; Zahradnikova, L; Zendulka, O | 1 |
| Fitzgerald, KD; Pekrul, SR | 1 |
| Alikhani, M; Almasi, A; Brand, S; Davarinejad, O; Farnia, V; Gharehbaghi, H; Golshani, S; Holsboer-Trachsler, E; Sadeghi Bahmani, D; Salemi, S; Tatari, F | 1 |
3 review(s) available for memantine and fluoxetine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New perspectives on molecular and genic therapies in Down syndrome].
Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction | 2010 |
Treatment options of cognitive impairment in multiple sclerosis.
Topics: Cholinesterase Inhibitors; Cognition Disorders; Fluoxetine; Humans; Interferon-beta; Memantine; Multiple Sclerosis; Neuropsychological Tests | 2010 |
1 trial(s) available for memantine and fluoxetine
| Article | Year |
|---|---|
Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial.
Topics: Adult; Anticonvulsants; Dopamine Agents; Double-Blind Method; Female; Fluoxetine; Gabapentin; Humans; Male; Memantine; Obsessive-Compulsive Disorder; Outpatients; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2018 |
10 other study(ies) available for memantine and fluoxetine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder.
Topics: Affective Symptoms; Amitriptyline; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Brain; Dextromethorphan; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Male; Memantine; Membranes; Radioligand Assay; Rats; Receptors, Neurotransmitter | 2007 |
The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder.
Topics: Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Male; Memantine; Mice; Obsessive-Compulsive Disorder; p-Methoxy-N-methylphenethylamine; Receptors, N-Methyl-D-Aspartate | 2009 |
Effects of combined treatment with cognitive enhancer memantine and antidepressant fluoxetine on CYP2D2 metabolic activity in rats.
Topics: Animals; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Brain; Cognition; Dextromethorphan; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Enzyme Activation; Excitatory Amino Acid Antagonists; Fluoxetine; Liver; Male; Memantine; Models, Animal; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2011 |
Memantine Augmentation in a Down's Syndrome Adolescent with Treatment- Resistant Obsessive-Compulsive Disorder.
Topics: Adolescent; Down Syndrome; Drug Synergism; Excitatory Amino Acid Antagonists; Fluoxetine; Humans; Male; Memantine; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 2015 |